Assuntos
Antibacterianos/metabolismo , Infecções Bacterianas/tratamento farmacológico , Doenças do Recém-Nascido/tratamento farmacológico , Tobramicina/metabolismo , Peso Corporal , Feminino , Meia-Vida , Humanos , Recém-Nascido , Infusões Parenterais , Rim/metabolismo , Cinética , Masculino , Taxa de Depuração Metabólica , Tobramicina/administração & dosagem , Tobramicina/sangueRESUMO
The delivery rates of chloramphenicol succinate from a standard pediatric intravenous infusion set were studied in vitro at varying flow rates and injection sites of the infusion set. The pharmacokinetic properties of CAPS and chloramphenicol were then studied in 15 children given intravenous injections of CAPS via the infusion set at the flashball and Buretrol sites in a crossover fashion on successive days. In vitro, the actual times required for 95% delivery of CAPS from the infusion set were two- to fourfold longer than the predicted infusion times at flow rates of 5, 15, and 29 ml/min and at all three available injection sites. In vivo, flashball injections vs Buretrol injections resulted in significantly higher mean peak serum concentrations of CAPS and CAP, with peaks occurring significantly sooner after the beginning of the intravenous infusion. These results suggest a need for considering characteristics of CAPS infusion when monitoring and interpreting serum concentration values.